Clinically translatable gold nanozymes with broad spectrum antioxidant and anti-inflammatory activity for alleviating acute kidney injury
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (20) , 9904-9917
Abstract
Rationale: Acute kidney injury (AKI) is associated with aberrant generation of oxidative species and inflammation, leading to high mortality of in-hospitalized patients. Although N-acetylcysteine (NAC) showed positive effects in alleviating contrast-induced AKI, the clinical applications are strongly restrained due to the low bioavailability, low renal accumulation, short renal retention time, and high dosage-induced toxicity.Keywords
This publication has 42 references indexed in Scilit:
- Mesoporous silica-encapsulated gold nanoparticles as artificial enzymes for self-activated cascade catalysisBiomaterials, 2013
- Plasma and Urinary Heme Oxygenase-1 in AKIJournal of the American Society of Nephrology, 2012
- In vivo renal clearance, biodistribution, toxicity of gold nanoclustersBiomaterials, 2012
- Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studiesNature Biotechnology, 2010
- Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissueNature Protocols, 2009
- Intensity of Renal Support in Critically Ill Patients with Acute Kidney InjuryNew England Journal of Medicine, 2008
- Community-based incidence of acute renal failureKidney International, 2007
- Systematic review of the impact of N-acetylcysteine on contrast nephropathyKidney International, 2004
- Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by AcetylcysteineNew England Journal of Medicine, 2000
- Superoxide dismutase, glutathione peroxidase, catalase, and lipid peroxidation in the major organs of the aging ratsFree Radical Biology and Medicine, 1989